Assessment of cardiac troponin I (cTnI) and tissue velocity imaging (TVI) in 14 dogs with malignant lymphoma undergoing chemotherapy treatment with doxorubicin.

@article{Tater2017AssessmentOC,
  title={Assessment of cardiac troponin I (cTnI) and tissue velocity imaging (TVI) in 14 dogs with malignant lymphoma undergoing chemotherapy treatment with doxorubicin.},
  author={Guy Tater and N. B. Eberle and S Hungerbuehler and Alexa E Joetzke and Ingo Nolte and Gerhard Wess and Daniela Betz},
  journal={Veterinary and comparative oncology},
  year={2017},
  volume={15 1},
  pages={
          55-64
        }
}
Doxorubicin has been shown to be cardiotoxic at high doses but is an efficacious chemotherapeutic agent in the treatment of canine lymphoma. Echocardiographic measurements and serum ultrasensitive cardiac troponin I (cTnI) levels were obtained before and after doxorubicin administration in 14 dogs diagnosed with lymphoma. The aim of this prospective study was to evaluate changes in cTnI concentrations and tissue velocity imaging (TVI) values in dogs with lymphoma undergoing chemotherapy with… CONTINUE READING
3
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 63 REFERENCES

Echocardiographic assessment of canine degenerative mitral valve disease.

  • Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology
  • 2012

Cardiac troponin-I concentrations in dogs with bradyarrhythmias before and after artificial pacing.

  • Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology
  • 2010